BRAINLIFE.ORG





Topics


Glioblastoma | Treatment | Targeted therapy | BRAF-MEK-inhibitors






Home > Publications > Topics > Glioblastoma > Treatment > Targeted therapy > BRAF-MEK-inhibitors






Steininger J, Buszello C, Oertel R, Meinhardt M, Schmid S, Engellandt K, Herold S, Stasik S, Ebrahimi A, Renner B, Thiede C, Eyüpoglu IY, Schackert G, Beissert S, Meier F, Radke J, Westphal D, Juratli TA.
Efficacy of BRAF/MEK-inhibitor therapy for epithelioid glioblastoma with a novel BRAFV600 mutation.
Acta Neuropathol Commun. 2024 Aug 6;12(1):124. doi: 10.1186/s40478-024-01834-8. PMID: 39107839. Case report. ˍ




Homma T, Suzuki T, Kato T, Shirahata M, Mishima K.
Cerebrospinal fluid cytology in a case of epithelioid glioblastoma.
Cytopathology. 2024 Aug 13. doi: 10.1111/cyt.13436. PMID: 39136219. Case report. ˍ